Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers

Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer

(2020) Zhiyu Wang et al.   Drug Design Development and Therapy

Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles

(2020) Ruifeng Wu et al.   Drug Design Development and Therapy

Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine

(2019) Yuan Hong et al.   BIOMEDICINE & PHARMACOTHERAPY

Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides

(2019) Gang Yang et al.   International Journal of Nanomedicine

Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy

(2019) Jing Xing et al.   International Journal of Nanomedicine

The antitoxic effects of quercetin and quercetin-conjugated iron oxide nanoparticles (QNPs) against H2O2-induced toxicity in PC12 cells

(2019) Zahra Yarjanli et al.   International Journal of Nanomedicine

Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer

(2019) Jing Zhang et al.   ACS Nano

Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin

(2018) Sheng Tan et al.   BIOMEDICINE & PHARMACOTHERAPY

Highly GSH-sensitive SN-38 prodrug with "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent

(2018) Chang-Hee Whang et al.   CHEMICAL COMMUNICATIONS

Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy

(2018) Jicai Zhang et al.   International Journal of Nanomedicine

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib

(2018) Wendu Duan et al.   Drug Design Development and Therapy

Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma

(2018) Chunhui Ruan et al.   Acta Pharmaceutica Sinica B

Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers

(2018) Zhiyu Wang et al.   Drug Design Development and Therapy

Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery

(2017) Kang Liu et al.   International Journal of Nanomedicine

Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer

(2017) Bo Liu et al.   International Journal of Nanomedicine

Drug release studies from lipid nanoparticles in physiological media by a new DSC method

(2017) Elin Roese et al.   JOURNAL OF CONTROLLED RELEASE

Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer

(2017) Rongrong Zhang et al.   Drug Design Development and Therapy

TAT modified and lipid – PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA

(2016) Shufang Dong et al.   BIOMEDICINE & PHARMACOTHERAPY

Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats

(2016) Shouwen Zhang et al.   DRUG DELIVERY

Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system

(2016) Wenjun Chen et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Global patterns and trends in colorectal cancer incidence and mortality

(2016) Melina Arnold et al.   GUT

Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors

(2016) Tao Fang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer

(2016) Li Lv et al.   Oncotarget

Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer

(2015) Ilkoo Noh et al.   BIOMATERIALS

Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma

(2015) Mingqing Yuan et al.   DRUG DELIVERY

Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA

(2015) Zhenyu Shao et al.   International Journal of Nanomedicine

Magnetoelectric ‘spin’ on stimulating the brain

(2015) Rakesh Guduru et al.   Nanomedicine

Synthesis of a reactive oxygen species responsive heterobifunctional thioketal linker

(2015) Xiaoxi Ling et al.   TETRAHEDRON LETTERS

Tumor Redox Heterogeneity-Responsive Prodrug Nanocapsules for Cancer Chemotherapy

(2013) Jinqiang Wang et al.   ADVANCED MATERIALS

Nanoparticles containing insoluble drug for cancer therapy

(2013) Shutao Guo et al.   BIOTECHNOLOGY ADVANCES

Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting

(2013) J P Tiernan et al.   BRITISH JOURNAL OF CANCER

Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform

(2012) Bivash Mandal et al.   Nanomedicine-Nanotechnology Biology and Medicine

A Decade of Advances in Cytotoxic Chemotherapy for Metastatic Colorectal Cancer

(2011) Amy S. Lucas et al.   Clinical Colorectal Cancer

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations

(2010) Prashant Bavi et al.   Molecular Cancer

Triplet Combination of Fluoropyrimidines, Oxaliplatin, and Irinotecan in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Gianluca Masi et al.   Clinical Colorectal Cancer